These results were statistically relevant and occurred independently of pretrial treatments (both insulin and non-insulin agents) but could be attributable to a poorer baseline glucose control and lower duration of diabetes (ONWARDS 1, 2, 3, and 5). This evidence concerns the gene INS and diabetes mellitus.